What has Advent Life Sciences invested in recently?

Recent investments include Beacon Therapeutics Limited, Cyted Ltd and Relief Cardiovascular. It made 1 investments in the last 12 months.

Where is Advent Life Sciences based?

Advent Life Sciences is headquartered in London, UK.

How do I contact Advent Life Sciences?

Partner names, emails and LinkedIn profiles for Advent Life Sciences are on the Capital Atlas Pro and Team plans, which also draft outreach and track replies. Check the stages and cheque size above first, so you pitch a firm that fits your round.

Advent Life Sciences

Venture Capital FirmLondon, UKFounded 2006adventls.com

Est. dry powder

$7.1M

Raised, not yet invested

AUM

—

Not reported

Latest fund

$145.7M

BioMotiv

Est. cheque size

$1.8M–$10.8M

From fund sizes

Deals, last 12 months

Last seen investing Dec 2025

About Advent Life Sciences

Advent Life Sciences is a United Kingdom-based venture capital firm focused on providing equity capital and active support to life sciences companies. The firm invests in early- and mid-stage businesses engaged in drug discovery, medical technology, enabling technologies, and vaccines, and works closely with management teams through development and clinical progress. Advent Life Sciences focuses on opportunities across the United Kingdom, Europe, and the United States.

Type: Venture Capital Firm
Headquarters: London, England, UK
Stages: SeedSeries ASeries BSeries CSeries DSeries ESeries HVenture Debt+1
Est. cheque size: $1.8M–$10.8M
Sectors: Healthcare, Industrials
Regions: Europe
Strategies: Growth

Where they invest

From deals and portfolio companies on record

Most frequent rounds

Series A28
Series B22
Series C12
Series D6
Seed5

Across 97 deals

Portfolio sectors

Biotechnology21
Pharmaceuticals16
Medical Devices & Equipment7
Healthcare2
Healthcare IT2

Across 50 companies

Portfolio countries

UK22
US22
Belgium1
Finland1
France1

Across 50 companies

Recent investments

Newest 5 of 97

Dec 2025
Beacon Therapeutics Limited
Dec 2025 · Series C
Series C$75MForbion, Goldman Sachs Asset Management, Syncona, Oxford Sciences Enterprises +1
Aug 2025
Cyted Ltd
Aug 2025 · Series B
Series B—EQT Life Sciences, BGF Investment Management, Morningside, British Business Bank
Jan 2025
Relief Cardiovascular
Jan 2025 · Series A
Series A$12MBroadview Ventures, Pacific Health Ventures, Heartwork Human Capital, LLC
Oct 2024
Epitopea Limited
Oct 2024 · Unspecified Round
Unspecified Round$31MInvestment Quebec, CTI Life Sciences, Cambridge Innovation Capital, adMare Bioinnovations +2
Sep 2024
F2G Ltd.
Sep 2024 · Series H
Series H$100MIntermediate Capital Group, Sofinnova Partners, Merifin Capital, Novo Holdings +5

Offices

1 location

London, England, UKHQ

Questions about Advent Life Sciences

How much does Advent Life Sciences invest per deal?

Based on the size of its funds, Advent Life Sciences writes estimated cheques of $1.8M–$10.8M. Lead cheques usually sit at the top of that range and follow-on cheques lower.

What stages does Advent Life Sciences invest in?

Advent Life Sciences has invested at Seed, Series A, Series B, Series C, Series D and Series E. Its most frequent rounds on record are Series A, Series B and Series C.

How much capital does Advent Life Sciences have left to invest?

Advent Life Sciences has an estimated $7.1M in dry powder: capital it has raised but not yet invested.

Similar investors in Europe

Index VenturesUK · Cheque $2.5M–$30M$4B dry powder ForbionNetherlands · Cheque $2.3M–$35.1M$2.4B dry powder European Investment Bank